Wolverine Blend (BPC-157 + TB-500) 60mg — Vial Spec, Reconstitution Math & COA

60mg Wolverine Blend Formulation Specs & Availability Overview

The 60mg Wolverine Blend research vial combines two extensively studied tissue-modulating peptides into a unified lyophilized matrix: 30mg of synthetic pentadecapeptide BPC-157 and 30mg of Thymosin Beta-4 synthetic fragment TB-500 (Thymosin Beta-4 17-23 fragment / N-acetylated peptide sequence). This 1:1 combination by weight provides a total active peptide mass of 60mg per vial, engineered specifically for high-volume research protocols, automated liquid handling systems, and multi-subject rodent studies.

To ensure precise volumetric distribution during high-throughput preclinical screening, maintaining precise control over total peptide concentration is critical. While PX1 Research maintains immediate stock of standard single-run testing configurations—such as our off-the-shelf 10mg Wolverine Blend vial containing 5mg BPC-157 and 5mg TB-500—the 60mg high-mass format is frequently produced for specialized institutional accounts. Academic laboratories and contract research organizations (CROs) requiring bulk batching, high-density plate assays, or custom 60mg mass fills can order directly through our institutional wholesale peptide accounts program to coordinate dedicated lot production and batch scheduling.

Reconstitution Math for 60mg Lyophilized Mass

Reconstituting a 60mg total lyophilized mass requires precise volumetric calculations to ensure accurate concentration parameters across assay plates or experimental animal subjects. Because the vial contains an aggregate 60mg of active lyophilized powder (30mg BPC-157 + 30mg TB-500), adding specific diluent volumes yields highly concentrated stock solutions. Researchers must account for the dual-component nature of the formulation when calculating concentration per individual peptide component.

When reconstituting with standard laboratory diluents such as bacteriostatic water (0.9% benzyl alcohol) or sterile physiological saline, consider the following concentration outputs based on diluent volume additions:

1.0 mL Diluent Addition: Yields a total peptide concentration of 60.0 mg/mL (comprising 30.0 mg/mL BPC-157 and 30.0 mg/mL TB-500). This high-density stock is ideal for primary aliquot distribution or concentrated micro-pipetting.

2.0 mL Diluent Addition: Yields a total peptide concentration of 30.0 mg/mL (comprising 15.0 mg/mL BPC-157 and 15.0 mg/mL TB-500). This concentration balances working viscosity with precise micro-liter volumetric measuring.

3.0 mL Diluent Addition: Yields a total peptide concentration of 20.0 mg/mL (comprising 10.0 mg/mL BPC-157 and 10.0 mg/mL TB-500). This standardized concentration simplifies mental math during high-frequency laboratory serial dilutions.

5.0 mL Diluent Addition: Yields a total peptide concentration of 12.0 mg/mL (comprising 6.0 mg/mL BPC-157 and 6.0 mg/mL TB-500). Recommended when larger working volumes are required for multi-subject preclinical dosing models.

Researchers calculating specific microliter delivery volumes based on targeted microgram-per-kilogram rodent model requirements should utilize the interactive PX1 reconstitution calculator to verify custom volumetric measurements before running assays.

Dual-Peptide Synergism: Preclinical Mechanisms of BPC-157 & TB-500

The co-formulation of BPC-157 and TB-500 in a single research compound allows investigators to analyze converging signaling pathways involved in tissue repair, cell migration, and vascularization. Preclinical studies suggest that while each peptide targets distinct cellular mechanisms, their combined administration produces complementary downstream signaling events in musculoskeletal, cutaneous, and vascular research models.

In vitro data indicate that BPC-157 research compounds—a 15-amino acid fragment derived from human gastric juice protein—acts predominantly through the focal adhesion kinase (FAK)-paxillin pathway and upregulates vascular endothelial growth factor receptor 2 (VEGFR2) expression. These signaling cascades promote early-stage focal adhesion assembly and accelerate capillary tube formation in endothelial cell culture models. Additionally, BPC-157 has been observed in animal models to modulate nitric oxide (NO) synthesis, contributing to cytoprotective mechanisms during oxidative tissue stress.

Conversely, cellular studies examining TB-500 research compounds—the active region of Thymosin Beta-4—demonstrate robust G-actin sequestering capabilities. By regulating actin polymerization dynamics, TB-500 facilitates rapid cell motility, keratinocyte migration, and extracellular matrix (ECM) reorganization. When investigated concurrently in fibroblast and endothelial co-cultures, preclinical evidence suggests that BPC-157 accelerates early receptor-mediated angiogenic signaling, while TB-500 supplies the structural cellular motility required for structural matrix reconstruction.

Analytical Quality Verification: Lot-Matched COA Protocols

Maintaining chemical integrity across high-mass peptide vials requires stringent analytical verification. Every lot of Wolverine Blend manufactured for PX1 Research undergoes rigorous testing in an ISO 17025 accredited analytical facility to ensure exact stoichiometric ratios, chemical purity, and biosafety before release.

Purity and identity are confirmed using High-Performance Liquid Chromatography (HPLC) coupled with Mass Spectrometry (MS). HPLC analysis confirms overall peptide purity levels exceeding 99.0%, ensuring the complete absence of truncated sequences or synthesis byproducts. Mass spectrometry confirms the molecular weight of both pentadecapeptide BPC-157 (1419.5 Da) and TB-500 (889.0 Da) within strict mass tolerances.

Because high-mass 60mg vials are frequently utilized in sensitive cell culture assays and live animal research models, biological safety parameters are strictly enforced. Bacterial endotoxin content is measured using standardized Limulus Amebocyte Lysate (LAL) chromogenic assays, enforcing a strict limit of <0.5 EU/mg. Purity verification, MS spectra, and endotoxin reports for every batch are accessible through our public certificate of analysis portal.

Aliquot Planning & Solution Stability in Laboratory Environments

Handling a high-yield 60mg peptide vial requires deliberate aliquot planning to avoid loss of active compound due to repeated freeze-thaw cycles or thermal degradation. Once reconstituted with a sterile, preservative-containing diluent such as bacteriostatic water, the working solution should be immediately subdivided into single-use microcentrifuge aliquots using pyrogen-free, low-binding polypropylene tubes.

Lyophilized peptide cake stored in its original sealed vial remains stable at -20°C to -80°C for up to 24 months. Following reconstitution, working aliquots intended for short-term use (within 14 to 28 days) should be maintained under refrigeration at 2°C to 8°C. For long-term observational protocols exceeding 30 days, reconstituted aliquots must be flash-frozen and preserved at -80°C to maintain molecular structural integrity.

Researchers must avoid exposing reconstituted peptide solutions to direct sunlight, high temperatures, or mechanical agitation (such as vigorous vortexing), as shear stress can cause peptide denaturing or aggregation, compromised potency, and inconsistent experimental results.

Comparative Analysis: Musculoskeletal & Repair Research Compounds

When establishing preclinical protocols for tissue regeneration or cellular repair, researchers often evaluate various peptide classes to target specific biological pathways. The dual-action Wolverine Blend provides a distinct mechanistic profile compared to single-component peptides or systemic secretagogues.

Compared to standalone administration of BPC-157 or TB-500, the combined 60mg formulation streamlines dosing schedules in dual-target studies by eliminating the need for separate reconstitutions and multiple administration protocols. However, in models where researchers must isolate distinct pathways—such as evaluating isolated VEGFR2 upregulation without actin-modulating effects—single-agent vials remain the methodologically superior choice.

In contrast to local structural repair peptides, growth hormone secretagogues such as CJC-1295 no DAC and Ipamorelin operate via systemic pituitary pathways. While secretagogues elevate endogenous growth hormone and IGF-1 axis signaling to influence systemic protein synthesis, the BPC-157/TB-500 blend acts locally at the cellular ECM level, targeting focal adhesion, cell migration, and localized microvascular sprouting.

Selecting Appropriate Vial Formulations: 10mg vs. 60mg Protocols

Choosing between a standard 10mg vial configuration and a high-capacity 60mg research vial depends on specific experimental parameters, study duration, subject group sizing, and laboratory liquid-handling equipment.

Standard 10mg Wolverine Blend vials (5mg BPC-157 / 5mg TB-500) are ideal for short-term pilot studies, single-subject rodent trials, or preliminary in vitro assay validation where lower working volumes prevent potential solution degradation over prolonged storage periods.

Conversely, high-mass 60mg vials are engineered for large-cohort longitudinal trials, automated robotic assay liquid handlers, and multi-litter animal protocols where batch consistency across hundreds of micro-doses is essential. Utilizing a single 60mg vial eliminates run-to-run variances associated with opening and reconstituting multiple smaller vials. Investigators can explore our complete range of available concentrations and research compounds in our comprehensive all peptides catalog.

PX1 Research Quality Standards & Logistics Overview

PX1 Research is committed to supplying the scientific community with reliable, high-purity research compounds manufactured under strict Quality Management Systems (QMS). All lyophilized peptides are synthesized in state-of-the-art, GMP-compliant facilities located in the United States.

To support rigorous laboratory timelines, PX1 Research operates dual dispatch centers in California and Arizona. Orders placed before cut-off times Monday through Friday receive same-day shipping, ensuring rapid domestic delivery and minimal transit disruption. Each shipment is packaged in insulated, temperature-controlled shipping materials designed to preserve the structural stability of delicate lyophilized cakes during transit.

Researchers seeking detailed experimental protocols, analytical data, or peptide synthesis documentation are encouraged to review our published literature in the dedicated PX1 peptides research hub.